CTRI/2024/03/064833尚未招募2 期
A clinico- dermoscopic study of comparison of intralesional triamcinolone acetonide, pentoxifylline and their combination in treatment of alopecia areata - NI
Vinayak Viswanath0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Clinically and dermoscopically diagnosed patients with single or multiple patches of alopecia areata
排除标准
- •1.Non-consenting patients
- •2.Patients with alopecia affecting more than 50% of scalp
- •3.Any treatment taken for alopecia in the past one month.
- •4.Prior history of allergic reactions to pentoxifylline, triamcinolone, or injection adjuvants or components
- •5.Pregnant and lactating females
- •6.Localised infection at injection site.
- •7.Known case of HIV, Hepatitis B and Hepatitis C or any other immune-compromised disease
- •8.Patient on systemic steroids or any other immunosuppressive treatment.
- •9. Acute febrile or any other bacterial infection.
- •10.Asthma, allergic skin disorder, history of convulsions
- •11.Bleeding disorders.
研究者
相似试验
尚未招募
Unknown
Studying drug reaction on skin and mucous membrane and performing dermoscopy in patients coming to sir t hospital bhavnagarCTRI/2024/06/068849Dr Ram jignashaben meramanbhai
尚未招募
2 期
Comparison of two treatment options for patients with precursor lesions of skin cancer: colchicine cream versus 5-FU creamL57.0Actinic keratosisRBR-487ctpInstituto Lauro de Souza Lima (ILSL)
招募中
不适用
A study to compare efficacy of intradermal Tranexamic acid injections versus topical Tranexamic acid gel versus topical triple combination (Hydroquinone 2 %, Tretinion 0.025%, Flucinolone acetonide 0.01%) cream in patients suffering from melasmaCTRI/2017/07/009158MGM Medical COllege and Hospital180
招募中
不适用
combined Nd:YAG laser and PRP injection for treatment of periorbital wrinklesSkin and Connective Tissue Diseasesperiorbital wrinklesPACTR201806003306192Faculty of Medicine for Girls, Al-Azhar University105
尚未招募
不适用
Clinico-epidemiological factors in hand eczema.CTRI/2022/09/045905society for eczema studies